rdf:type |
|
lifeskim:mentions |
umls-concept:C0000768,
umls-concept:C0003873,
umls-concept:C0004358,
umls-concept:C0030705,
umls-concept:C0032854,
umls-concept:C0205269,
umls-concept:C0332281,
umls-concept:C0546816,
umls-concept:C0871261,
umls-concept:C1167395,
umls-concept:C1328050,
umls-concept:C1504389,
umls-concept:C1550315,
umls-concept:C1561558,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2348628,
umls-concept:C2911692
|
pubmed:issue |
12
|
pubmed:dateCreated |
2005-11-14
|
pubmed:abstractText |
Immunoablative therapy combined with haematopoietic stem cell transplantation (SCT) is a possible treatment for patients with severe rheumatoid arthritis (RA).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0003-4967
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1783-5
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:16284342-Adult,
pubmed-meshheading:16284342-Antirheumatic Agents,
pubmed-meshheading:16284342-Arthritis, Rheumatoid,
pubmed-meshheading:16284342-Autoantibodies,
pubmed-meshheading:16284342-Cyclophosphamide,
pubmed-meshheading:16284342-Female,
pubmed-meshheading:16284342-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:16284342-Humans,
pubmed-meshheading:16284342-Immunosuppressive Agents,
pubmed-meshheading:16284342-Synovial Membrane,
pubmed-meshheading:16284342-Treatment Failure
|
pubmed:year |
2005
|
pubmed:articleTitle |
High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
|
pubmed:affiliation |
Department of Rheumatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Case Reports
|